These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 26259086)

  • 1. Advances in Medications and Tailoring Treatment for Alcohol Use Disorder.
    Seneviratne C; Johnson BA
    Alcohol Res; 2015; 37(1):15-28. PubMed ID: 26259086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacogenetics of alcohol use disorder.
    Jones JD; Comer SD; Kranzler HR
    Alcohol Clin Exp Res; 2015 Mar; 39(3):391-402. PubMed ID: 25703505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of the Genetics of Alcohol Use Disorder.
    Tawa EA; Hall SD; Lohoff FW
    Alcohol Alcohol; 2016 Sep; 51(5):507-14. PubMed ID: 27445363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Care Providers' Interest in Using a Genetic Test to Guide Alcohol Use Disorder Treatment.
    Williams EC; Young JP; Achtmeyer CE; Hendershot CS
    J Subst Abuse Treat; 2016 Nov; 70():14-20. PubMed ID: 27692183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex Differences in Alcohol Use Disorder.
    Agabio R; Pisanu C; Gessa GL; Franconi F
    Curr Med Chem; 2017; 24(24):2661-2670. PubMed ID: 27915987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.
    Rinker JA; Mulholland PJ
    Pharmacogenomics; 2017 Apr; 18(6):555-570. PubMed ID: 28346058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity.
    Cservenka A; Yardley MM; Ray LA
    Am J Addict; 2017 Aug; 26(5):516-525. PubMed ID: 28134463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing access to alcohol use disorder pharmacotherapy and treatment in primary care settings: ADaPT-PC.
    Hagedorn HJ; Brown R; Dawes M; Dieperink E; Myrick DH; Oliva EM; Wagner TH; Wisdom JP; Harris AH
    Implement Sci; 2016 May; 11():64. PubMed ID: 27164835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain Imaging-Guided Analysis Reveals DNA Methylation Profiles Correlated with Insular Surface Area and Alcohol Use Disorder.
    Zhao Y; Ge Y; Zheng ZL
    Alcohol Clin Exp Res; 2019 Apr; 43(4):628-639. PubMed ID: 30830696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review.
    Manhapra A; Chakraborty A; Arias AJ
    J Addict Med; 2019; 13(1):7-22. PubMed ID: 30096077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dimensionality and stages of severity of DSM-5 criteria in an international sample of alcohol-consuming individuals.
    Preuss UW; Watzke S; Wurst FM; ;
    Psychol Med; 2014 Nov; 44(15):3303-14. PubMed ID: 25065388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of medications for alcohol use disorders: recent advances and ongoing challenges.
    Litten RZ; Fertig J; Mattson M; Egli M
    Expert Opin Emerg Drugs; 2005 May; 10(2):323-43. PubMed ID: 15934870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The harmful dysfunction model of alcohol use disorder: revised criteria to improve the validity of diagnosis and prevalence estimates.
    Wakefield JC; Schmitz MF
    Addiction; 2015 Jun; 110(6):931-42. PubMed ID: 25622535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Service delivery and pharmacotherapy for alcohol use disorder in the era of health reform: Data from a national sample of treatment organizations.
    Knudsen HK; Roman PM
    Subst Abus; 2016; 37(1):230-7. PubMed ID: 25893539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drosophila and Caenorhabditis elegans as Discovery Platforms for Genes Involved in Human Alcohol Use Disorder.
    Grotewiel M; Bettinger JC
    Alcohol Clin Exp Res; 2015 Aug; 39(8):1292-311. PubMed ID: 26173477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic treatment of alcoholism.
    Anton RF; Schacht JP; Book SW
    Handb Clin Neurol; 2014; 125():527-42. PubMed ID: 25307594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development.
    Litten RZ; Falk DE; Ryan ML; Fertig JB
    Alcohol Clin Exp Res; 2016 Jul; 40(7):1368-79. PubMed ID: 27184259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AUDIT-C scores as a scaled marker of mean daily drinking, alcohol use disorder severity, and probability of alcohol dependence in a U.S. general population sample of drinkers.
    Rubinsky AD; Dawson DA; Williams EC; Kivlahan DR; Bradley KA
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1380-90. PubMed ID: 23906469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of animal models of alcohol-related behavior.
    Crabbe JC
    Handb Clin Neurol; 2014; 125():71-86. PubMed ID: 25307569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.